journal article·2024-06-12

A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing

Shuang Liang, Ning Ma, Xingang Li, Kaiqing Yun, Qian-Fang Meng, Kongshuo Ma, Ludan Yue, Lang Rao, Xiaoyuan Chen, Zhaohui Wang

Nano Letters· Volume 24· Issue 23
Publisher page

Abstract

The efficient cytosolic delivery of the CRISPR-Cas9 machinery remains a challenge for genome editing. Herein, we performed ligand screening and identified a guanidinobenzol-rich polymer to overcome the cascade delivery barriers of CRISPR-Cas9 ribonucleoproteins (RNPs) for genome editing. RNPs were stably loaded into the polymeric nanoparticles (PGBA NPs) by their inherent affinity. The polymer facilitated rapid endosomal escape of RNPs via a dynamic multiple-step cascade process. Importantly, the incorporation of fluorescence in the polymer helps to identify the correlation between cellular uptake and editing efficiency, increasing the efficiency up to 70% from the initial 30% for the enrichment of edited cells. The PGBA NPs efficiently deliver RNPs for in vivo gene editing via both local and systemic injections and dramatically reduce PCSK9 level. These results indicate that PGBA NPs enable the cascade delivery of RNPs for genome editing, showing great promise in broadening the therapeutic potential of the CRISPR-Cas9 technique.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: CRISPR and Genetic Engineering · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518132, China

Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore 119074, Singapore

Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore

Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore

Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), Singapore 138673, Singapore

Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, 1 Biopolis Way, Helios 138667, Singapore

Funding

Chinese Academy of Medical Sciences · Beijing Municipal Natural Science Foundation · National University of Singapore · National Natural Science Foundation of China · Shenzhen Medical Research Fund

References (35)

Show source-provided references
1. 10.1038/541030c10.1038/541030c ↗
2. 10.1021/sb500351f10.1021/sb500351f ↗
3. 10.1126/science.123203310.1126/science.1232033 ↗
4. 10.1038/nbt.284210.1038/nbt.2842 ↗
5. 10.1038/nm.379310.1038/nm.3793 ↗
6. 10.1016/j.molcel.2021.12.00210.1016/j.molcel.2021.12.002 ↗
7. 10.1038/nbt.262310.1038/nbt.2623 ↗
8. 10.1038/mt.2016.810.1038/mt.2016.8 ↗
9. 10.1038/s41578-019-0145-910.1038/s41578-019-0145-9 ↗
10. 10.1126/sciadv.abp943510.1126/sciadv.abp9435 ↗
11. 10.1038/s41551-017-0158-x10.1038/s41551-017-0158-x ↗
12. 10.1126/sciadv.abj062410.1126/sciadv.abj0624 ↗
13. 10.1093/nar/gkx79710.1093/nar/gkx797 ↗
14. 10.1002/anie.20200564410.1002/anie.202005644 ↗
15. 10.1016/j.nantod.2022.10148210.1016/j.nantod.2022.101482 ↗
16. 10.1002/anie.20210703610.1002/anie.202107036 ↗
17. 10.1002/anie.20211656910.1002/anie.202116569 ↗
18. 10.1038/s41392-021-00642-z10.1038/s41392-021-00642-z ↗
19. 10.1038/nbt.265410.1038/nbt.2654 ↗
20. 10.16476/j.pibb.2022.038910.16476/j.pibb.2022.0389 ↗
21. 10.1002/anie.20221498710.1002/anie.202214987 ↗
22. 10.1016/j.cell.2022.03.04510.1016/j.cell.2022.03.045 ↗
23. 10.1002/adma.20190257510.1002/adma.201902575 ↗
24. 10.1021/cr500279h10.1021/cr500279h ↗
25. 10.1021/acscentsci.0c0164810.1021/acscentsci.0c01648 ↗
26. 10.1016/j.jconrel.2020.01.05610.1016/j.jconrel.2020.01.056 ↗
27. 10.1021/jacs.7b0881610.1021/jacs.7b08816 ↗
28. 10.1021/cr940534g10.1021/cr940534g ↗
29. 10.1126/sciadv.abj940610.1126/sciadv.abj9406 ↗
30. 10.1073/pnas.76.12.646110.1073/pnas.76.12.6461 ↗
31. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
32. 10.1126/science.650567910.1126/science.6505679 ↗
33. 10.1016/S0304-3835(00)00569-310.1016/S0304-3835(00)00569-3 ↗
34. 10.1126/sciadv.abb177710.1126/sciadv.abb1777 ↗
35. 10.1161/CIRCULATIONAHA.122.06213210.1161/CIRCULATIONAHA.122.062132 ↗